Your browser doesn't support javascript.
loading
The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools.
Ferrari, Bruna Letícia; Neto, Guilherme de Carvalho Campos; Nucci, Mariana Penteado; Mamani, Javier Bustamante; Lacerda, Shirley Silva; Felício, André Carvalho; Amaro, Edson; Gamarra, Lionel Fernel.
Afiliação
  • Ferrari BL; Hospital Israelita Albert Einstein.
  • Neto GCC; Hospital Israelita Albert Einstein.
  • Nucci MP; LIM44, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Mamani JB; Hospital Israelita Albert Einstein.
  • Lacerda SS; Hospital Israelita Albert Einstein.
  • Felício AC; Hospital Israelita Albert Einstein.
  • Amaro E; Hospital Israelita Albert Einstein.
  • Gamarra LF; Hospital Israelita Albert Einstein.
Medicine (Baltimore) ; 98(45): e17824, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31702636
ABSTRACT
The hippocampus is one of the earliest sites involved in the pathology of Alzheimer's disease (AD). Therefore, we specifically investigated the sensitivity and specificity of hippocampal volume and glucose metabolism in patients being evaluated for AD, using automated quantitative tools (NeuroQuant - magnetic resonance imaging [MRI] and Scenium - positron emission tomography [PET]) and clinical evaluation.This retrospective study included adult patients over the age of 45 years with suspected AD, who had undergone fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET-CT) and MRI. FDG-PET-CT images were analyzed both qualitatively and quantitatively. In quantitative volumetric MRI analysis, the percentage of the total intracranial volume of each brain region, as well as the total hippocampal volume, were considered in comparison to an age-adjusted percentile. The remaining brain regions were compared between groups according to the final diagnosis.Thirty-eight patients were included in this study. After a mean follow-up period of 23 ±â€Š11 months, the final diagnosis for 16 patients was AD or high-risk mild cognitive impairment (MCI). Out of the 16 patients, 8 patients were women, and the average age of all patients was 69.38 ±â€Š10.98 years. Among the remaining 22 patients enrolled in the study, 14 were women, and the average age was 67.50 ±â€Š11.60 years; a diagnosis of AD was initially excluded, but the patients may have low-risk MCI. Qualitative FDG-PET-CT analysis showed greater accuracy (0.87), sensitivity (0.76), and negative predictive value (0.77), when compared to quantitative PET analysis, hippocampal MRI volumetry, and specificity. The positive predictive value of FDG-PET-CT was similar to the MRI value.The performance of FDG-PET-CT qualitative analysis was significantly more effective compared to MRI volumetry. At least in part, this observation could corroborate the sequential hypothesis of AD pathophysiology, which posits that functional changes (synaptic dysfunction) precede structural changes (atrophy).
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interpretação de Imagem Radiográfica Assistida por Computador / Fluordesoxiglucose F18 / Doença de Alzheimer / Disfunção Cognitiva / Hipocampo Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interpretação de Imagem Radiográfica Assistida por Computador / Fluordesoxiglucose F18 / Doença de Alzheimer / Disfunção Cognitiva / Hipocampo Idioma: En Ano de publicação: 2019 Tipo de documento: Article